The Democratic Republic of the Congo (DRC) yesterday announced a new Ebola case, its first since September, which involves a woman who died from her infection in Butembo, one of the main hot spots in the country's 10th outbreak that was centered in North Kivu and Ituri provinces.
A Rift Valley fever (RVF) outbreak in Kenya that began in the middle of November has led to 21 infections, 9 of them fatal, the World Health Organization (WHO) African regional office said yesterday in its weekly outbreaks and health emergencies report.
Merck's Ervebo vaccine is currently the sole stockpile product, with a planned-for 500,000 doses.
A study in JAMA Internal Medicine today demonstrates a sharp decline in US hospital COVID-19 mortality rates during the first 6 months of the pandemic, with wide variation across hospitals and poorer outcomes linked to higher county-level case rates.
A year after the 2014 Ebola outbreak in Boende, Democratic Republic of the Congo, 22.5% of healthcare workers (HCWs) had Ebola virus (EBOV) antibodies in their blood, even though only 15.1% reported contact with suspected, probable, or confirmed Ebola virus patients, according to a study today in The Journal of Infectious Diseases.
CARB-X today announced two new funding awards for German scientists working on therapies for difficult-to-treat bacterial infections.
After almost 6 months, 130 cases, and 55 deaths in Equateur province, the outbreak is officially over.
A study published late last week in the British Dental Journal suggests that restricted access to dental care in England during the early months of the COVID-19 pandemic resulted in a sharp rise in dental antibiotic prescribing.
While the Minnesota Department of Natural Resources (DNR) hoped that 50% of firearm hunters in the state's five chronic wasting disease (CWD) management zones would submit deer for voluntary testing, opening weekend saw well below 30% participation, according to a story last week in the Minneapolis Star Tribune.
Sports cardiologists in JAMA Cardiology yesterday updated guidance for athletes returning to play (RTP) after COVID-19 infection. The authors recommended a risk stratification approach, with screening for cardiac injury only for athletes with severe disease or preexisting cardiovascular (CV) conditions.